CLOVER HEALTH INVESTMENTS, CORP. /DE·4

Jul 17, 5:26 PM ET

Reynoso Jamie L. 4

4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Clover Health (CLOV) Jamie L. Reynoso Sells 4,839 Shares

What Happened Jamie L. Reynoso, CEO — Medicare Advantage at Clover Health Investments, sold 4,839 shares on July 17, 2026. The sales generated approximately $21,921, reported at a weighted-average price of $4.53 per share (individual trade prices ranged $4.35–$4.63). This was a sale (S), not a purchase.

Key Details

  • Transaction date: 2026-07-17 (reported same day).
  • Shares sold: 4,839; weighted-average price: $4.53; total proceeds reported: $21,921.
  • Price range: $4.35 to $4.63 across multiple trades; filer can provide breakdown by price on request (see footnote).
  • Footnote: Sale was executed pursuant to a Rule 10b5-1 trading plan adopted March 12, 2026.
  • Shares owned after transaction: Not stated in the provided Form 4.
  • Filing timeliness: Reported for the same period date (no late filing indicated).

Context

  • Sale under a 10b5-1 plan indicates the trades were preplanned; this is a routine disposition rather than an ad hoc sale. For retail investors, purchases generally convey stronger affirmative signals than routine sales. No options exercise, gift, or tax-withholding event is reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-07-17
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
  • Sale

    Class A Common Stock

    [F1][F2]
    2026-07-17$4.53/sh4,839$21,9212,814,640 total
Footnotes (2)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Signature
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso|2026-07-17

Documents

1 file
  • 4
    wk-form4_1784323597.xmlPrimary

    FORM 4